Boston Valuation Team to Present at the Cambridge Innovation Center
Jim Dondero, Chris Jones and Jackie O’Loughlin will present Valuations: The What & Why on Thursday, January 24th. The presentation will take place from 5 to 6:00pm in the Kathmandu conference room on the fourth floor of the Cambridge Innovation Center. It is open to the public and attendees will be encouraged to stay for networking at the Venture Café.
Valuations: The What & Why will discuss 409A valuations and why they matter to you, your company and your employees. The team will have models of common equity structures used by early stage companies to discuss each structure’s affect on valuation. With additional commentary on how the value of your company flows, the value impact of terms and common barriers that a substandard valuation can create.
This event will be held in conjunction with Venture Café, a weekly networking event where those in the local entrepreneurial community gather. Visitors must comply with Venture Café attendance policies (see http://bit.ly/vc-credo for more details.)
For more information, please visit http://wtasval.eventbrite.com.
Jim Dondero has over 30 years of experience advising clients on business and valuation matters. His focus is on valuations for tax and financial reporting for both closely held and publicly traded companies. He has worked with clients in the technology, consumer goods and services, hospitality, biotechnology, medical device, financial services industries and software.
Jackie O’Loughlin has over seven years of experience in providing valuation and financial analysis for financial reporting, tax, and transaction related matters. She has provided valuation services across a range of industries including software, franchise, hospitality, medical devices, scientific products, vehicle rental, and manufacturing.
Chris Jones has over seven years of experience advising clients on business and valuation matters. His experience relates to a variety of matters including purchase price allocations, goodwill and indefinite-lived intangible asset impairment studies, complex financial instruments, and common and preferred stock valuations.